drugset / Trial / NCT03478306
Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
Phase 3
Completed
31 enrolled
Glostrup University Hospital, Copenhagen
Steno Diabetes Center Copenhagen · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study evaluates the effect of melatonin 4 mg on circadian rhythm and visual function of patients with diabetes mellitus. Half of the patients will receive melatonin (arm-1) and the other half will receive placebo (arm-2), both groups in 3 weeks. After a week of washout, the patients will cross over to the other treatment arm.
Timeline
- Start
- 2018-03-27
- Primary completion
- 2021-06-12
- Completion
- 2021-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 4 mg | — |